Pharmaceutical Business Review
Anonymous User | Login

CHMP Recommends Novartis' EU Approved Afinitor For Patients With Advanced Kidney Cancer

Published: 29-May-2009

Novartis has received a positive response from the Committee for Medicinal Products for Human Use (CHMP), supporting European Union (EU) approval of Afinitor (everolimus) tablets for the treatment of patients with advanced renal cell carcinoma (RCC).

CHMP has recommended the approval of Afinitor based on data demonstrating that (when compared with placebo) Afinitor more than doubled the time without tumor growth or death in patients with advanced kidney cancer, whose disease progressed following prior therapy. Additionally, the data showed that Afinitor reduced the risk of disease progression or death by 67%.

David Epstein, President and CEO of Molecular Diagnostics at Novartis Oncology, said: This positive opinion is good news for those living with advanced kidney cancer and puts us one step closer to offering these patients a new treatment choice that will fulfill an important unmet medical need.

We also are studying the role of Afinitor for early kidney cancer, as well as its potential as a treatment for other tumor types, he added.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

Turku Region

A Bright Future in a Great Location ...

TNO

Pharma Services: From Discovery to the Clinic ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Thermo Fisher Scientific

The world leader in serving science ...

Tecnosoft

Monitoring Systems for Temperature, Humidity and Pressure ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Your IP at Risk in Collaborations!

Free white paper: Ten steps to protect your R&D investment within partnerships. ...

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...

Why CAPA Still Matters

This free white paper explores the needs and effectiveness of correct CAPA control, how to ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly

Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Related Companies

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Merck KGaA

Merck KGaA (Merck) is a Germany-based company engaged in the manufacturing and distribu ...

Wyeth

Wyeth is engaged in developing and providing pharmaceuticals and healthcare products fo ...

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manuf ...

Johnson & Johnson

Johnson & Johnson (J&J) is engaged in the manufacture and sales of broad range of healt ...

Suppliers Product News

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Finland's Business Environment Ranked Best in the World

The authoritative Economist Intelligence Unit has ranked Finland's business environment as the best in the world for the period 2009-2013.

Finland is the World's Most Prosperous Nation

According to the latest Legatum Prosperity Index, the Finnish economy and society enjoy many of the factors that help drive economic growth and produce happy citizens over the long term. Published for the third time, the Legatum Prosperity Index rates more than 100 nations worldwide according to how well they cultivate empirically-tested drivers of economic and social wellbeing.

Amarna Therapeutics B.V. and TNO Announce SVac Research and Development Partnership

Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna's viral gene delivery platform SVac.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address